From booklets for kids to information for adults, schools and health care professionals we have a whole range of resources for you to use. Plus, research, reports, all of our newsletters and other useful materials.
For the first time in over 20 years, a new treatment for sickle cell has been made available on the NHS. Crizanlizumab will be made available on the NHS under a Managed Access Agreement (MAA), following the National Institute for Health and Care Excellence’s (NICE) recommendation of crizanlizumab as an option for preventing recurrent sickle cell crises.
Find out more about this new treatment with our simple guide: www.sicklecellsociety.org/crizanlizumab/